What's Happening?
The American Cancer Society (ACS) has released updated guidelines for colorectal cancer screening, emphasizing new blood-based and at-home stool testing options. These updates aim to increase participation in colorectal cancer screening by providing more
accessible and varied testing methods. The guidelines recommend that average-risk adults begin screening at age 45 and continue until age 75, with a focus on early detection to improve survival rates. The new options include a blood-based test and updated at-home stool tests that detect hidden blood and molecular markers. Despite these new methods, colonoscopy remains the gold standard for screening. The ACS aims to close the screening gap, as over 20 million eligible Americans have not been tested as recommended.
Why It's Important?
The updated guidelines are significant as they aim to increase colorectal cancer screening rates, which can lead to early detection and improved survival rates. Colorectal cancer is a leading cause of cancer-related deaths, particularly among adults under 50. By offering more screening options, the ACS hopes to make testing more accessible, especially for underserved and minority populations. The changes also reflect a shift in public health strategy to lower barriers to access and ensure preventive care is available to all. The ACS's advocacy efforts continue to focus on eliminating out-of-pocket costs and other barriers to screening.
What's Next?
The ACS will continue to monitor the implementation and effectiveness of these new screening options. Ongoing evaluation of adherence and clinical outcomes will inform future updates to the guidelines. The ACS Cancer Action Network will advocate for policies that improve access to screening, focusing on coverage and affordability. The organization aims to ensure that all eligible individuals have the opportunity to receive evidence-based screening, regardless of socioeconomic status.
